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ABSTRACT
Melanoma and non-melanoma (basal cell and squamous cell carcinoma) skin cancer (NMSC) have
been recognized as an epidemic as they happen to be the most common type of cancers in the white
population. Cancer cell targeting i.e. differentiating cancer cells from normal cells has been an
area of active research to reduce the side effects of cancer chemotherapy. For this research project,
we have developed a novel light sensitive Methylene Blue (MB)-Polyethylene glycol (PEG)
conjugate with significant surfactant properties. The aim of this study was to synthesize a smart
light sensitive polymer which activates and releases the encapsulated drug on exposure to Near
Infrared radiation (NIR). This activation of the drug delivery systems on exposure to external
stimuli can find applications in targeted therapy and diagnosis of NMSC. The synthesis of this
novel conjugate is a six-step process conducted in a controlled environment with established
protocols. The synthesized intermediates and final products were subjected to NMR
characterizations and presumed structures were confirmed with the same. The final structure was
confirmed with 1H-NMR and FT-IR characterizations. After synthesizing the conjugate, we
subjected it to NIR radiation to evaluate its light sensitivity. We determined the surface activity
and critical micellar concentration (CMC) of the conjugate using tensiometry. The micelle forming
capability of the conjugate was used to encapsulate a model chemotherapeutic agent i.e. Paclitaxel.
The micelles were characterized based on their loading efficiency, encapsulation efficiency and in
vitro release studies which were in agreement with the expectations.
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CHAPTER I: INTRODUCTION
Epidemiological evaluation of twenty large regions of the world in 2012 suggested 14.1 million
new cases and 8.2 million deaths attributed to cancer and this number has only increased since
then[1][6]. Cancer is a genetic disease which results from genetic mutation or in simpler words
change in the genetic makeup which controls normal functioning of the cell, specifically growth
and division[19]. Cancer cells have the capability of manipulating and influencing the molecules,
normal cells and blood vessels surrounding and feeding the tumor also known as the tumor
microenvironment[19]. With their capabilities of hiding from the immune response and acquiring
all the resources required for feeding the tumor, cancer chemotherapy requires targeting. For the
longest time the Enhanced Permeability and Retention (EPR) effect in tumors had stood as one of
the fundamental principles of cancer drug delivery, holding the promise of safe, simple and
effective therapy by allowing nanoparticles preferential access to tumors by virtue of size and
longevity in circulation[3][4]. Though this rationale seemed well justified by the preclinical evidence
and the clinical success of Doxil®, recent clinical investigations have suggested that EPR effect is
not as reliable as previously thought[3]. This failure of EPR effect in clinical trials is attributed to
the large number of variables in the tumor microenvironment such as the tumor size, interstitial
fluid pressure (IFP), irregular vascular tissue distribution and poor blood flow inside the tumors.
Hence, it is suggested to exploit the EPR effect on a case-by-case-basis[3][4][14].
Clinical failure of EPR effect led to the discovery of specific cancer targeting mechanisms such as
employing biomarkers (peptides and proteins) which provide high specificity[20] but struggle
1

with stability and potential immunogenicity[17]. Exploiting the characteristics of the tumor
microenvironment is another potential targeting alternative as the tumor microenvironment has an
acidic characteristic pH[16], high levels of Reactive Oxygen Species (ROS)[2] and hence increased
levels of biological antioxidants and enzymes like glutathione peroxidase which can be exploited
for targeting[22]. Recently, extensive research on employing physical stimuli such as heat[21],
electrical stimuli[17], light[18] and magnetic stimuli[5][7] for cancer targeting have been explored as
these mechanisms eliminate the risk of premature release and provide the benefit of specific
targeting. For this research project Polyethylene Glycol (Methyl Ether) was modified by
conjugating it with methylene blue. This induces self-assembling properties to the conjugate for
drug encapsulation, light sensitivity on exposure to N-IR radiation (which penetrates to deep
tissues)[23] and sensitivity to ROS which stimulates drug release by the breakdown of the
nanocarrier.

Figure 1. Structure of POEM.
A moiety with light sensitivity and surfactant property can be used to load potent, water insoluble
chemotherapeutic agents[9][12] and the release of these agents can be facilitated by exposure of light
over the tumor. Light sensitive nanoparticles can be used extensively for the treatment of
2

Melanoma and Non-Melanoma (basal cell and squamous cell carcinoma) skin cancer (NMSC).

Figure 2. Release of MB from POEM on exposure to UV, N-IR and ROS.
The synthesis of this light sensitive conjugate with surface activity consists of three major steps
i.e. conjugating the linker (octamethylene diamine) with polyethylene glycol (methyl ether),
synthesis of activated methylene blue conjugated with ethanolamine and finally conjugating the
PEG-Linker with activated methylene blue-ethanolamine conjugate.
The first step of this synthesis (PEG-Linker) involves activation of PEG using 4-Nitrophenyl
chloroformate[11]. This PEG resin activation is conducted at room temperature in the presence of
an amine base which leads to a nucleophilic substitution reaction with the release of hydrochloric
acid (HCl) as a byproduct. This activated PEG is then conjugated with octamethylene diamine
(linker) through aminolysis of the carbonate group with nitrophenol as a byproduct as shown in
the reaction mechanism scheme below. The PEG-Linker is the first reactant for the final synthetic
phase.
The second step involves conjugation of methylene blue with ethanolamine and activating this
conjugate using NPC[8][11]. Firstly, methylene blue is reduced to leuco-methylene blue which is
colorless using sodium dithionite (reducing agent). Leuco-methylene blue is then activated using
4-NPC by nucleophilic substitution reaction. The amide moiety is converted into carbamide by
aminolysis induced by ethanolamine with nitrophenol released as a byproduct. The synthesized
MB-EA is again activated using 4-NPC. The hydroxyl group present at the terminal end of MB3

EA is activated to MB-EA-NPC by a nucleophilic substitution reaction with HCl as a byproduct.
MB-EA-NPC is the second reactant for the final synthetic phase.
Finally, PEG-Linker is reacted with MB-EA-NPC which leads to the aminolytic cleavage of the
carbonate group at room temperature. This leads to the synthesis of Polyethylene GlycolOctamethylene diamine-Ethanolamine-Methylene blue (PEG-Linker-EA-MB) with nitrophenol as
a byproduct. The structure can be divided into two regions hydrophilic and hydrophobic. Where
the polyethylene glycol chain is extremely hydrophilic, and Linker-EA-MB is hydrophobic. This
distribution of hydrophobicity and hydrophilicity suggests potential non-ionic, amphiphilic surface
activity[12].
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CHAPTER II: METHODOLOGY
Materials
Methylene blue (MB), 4-Nitrophenyl chloroformate (NPC), Ethanolamine (EA), Poly (Ethylene
glycol) Methyl Ether 2000, Octamethylene Diamine, Paclitaxel, Triethylamine, Sodium sulphate,
Sodium bicarbonate, Sodium carbonate, Hydrochloric acid, Sodium chloride, Toluene, Dichloro
methane, Acetonitrile, Acetone, Tetrahydrofuran, Diethyl ether, Ethyl acetate, Methanol,
Deionized water, Hexane, Activated silica gel, Sand, Sodium salicylate.
Methods
Synthesis of Polyethylene Glycol (PEG)-Octamethylene diamine (Linker)
The PEG-Linker was synthesized in two steps i.e. activation of PEG using 4-nitrophenyl
chloroformate (NPC) and then conjugating octamethylene diamine on the activated PEG.

Figure 3. Schematic representation of the synthesis of PEG-Linker (1) Activation of PEG 2000
(2) Conjugation of the linker with activated PEG 2000.

5

Activation of PEG
5g of PEG 2000 was dissolved in 50 ml of toluene with heating. The PEG was dried using a DeanStark tube with reflux by increasing the temperature from 60C to 120C. Bringing the volume as
low as 10 ml to this 10 ml of dichloromethane (DCM) was added. This mixture was transferred to
a round bottom flask (RBF). Excess NPC (five times the quantity if PEG 2000) was dissolved in
minimal quantity of DCM and using a dropper, NPC was added into the RBF. Triethylamine
(TEA) was added to the RBF to provide basicity to the solution. The reaction was conducted for
12 hours at room temperature and the progress of the reaction was monitored using TLC plates.
Once the reaction was complete, the product was subjected to purification by adding the solution
of the crude product into a flask containing cold diethyl ether with continuous stirring for 45
minutes (amount of diethyl ether was taken in excess). The precipitated PEG-NPC was again
subjected to purification by precipitation using diethyl ether twice before drying it. The dried
precipitates were recrystallized using ethyl acetate. The dried PEG-NPC was characterized using
1H

NMR.

Conjugation of activated PEG with Octamethylene diamine
Excess linker was dissolved in 2 ml of methanol and then volume was adjusted up to 10 ml with
DCM. To this solution TEA was added to maintain basic reaction conditions. PEG-NPC (activated
PEG) was dissolved in 10 ml of DCM and then added dropwise into the RBF containing the linker
solution. The reaction was conducted at room temperature for 12 hours and the progress of the
reaction was checked using TLC plates. The final product was purified using an excess of cold
diethyl ether and the precipitate was subjected to purification by precipitation two times before
drying. The dried product was recrystallized using ethyl acetate and then characterized using 1H
NMR.
6

Synthesis of Methylene Blue (MB)-Ethanolamine (Linker)-4 Nitrophenyl chloroformate
(Activator)
The hydrophobic part of the surfactant backbone was prepared by conjugation of methylene blue
with ethanolamine. This was performed in three steps i.e. activation of MB using 4-nitrophenyl
chloroformate (NPC), conjugation of activated MB with ethanolamine and finally activation of
MB-EA using NP.

Figure 4. Synthesis of activated MB-EA (1) activation of MB (2) Cojugation of MB with EA (3)
Activation of MB-EA
Activation of Methylene blue using 4-Nitrophenyl chloroformate
2 g methylene blue was dissolved in 50 ml of de-ionized water using acetone and then heated at
50 ºC (to evaporate acetone) to this 125 ml of toluene and quantity sufficient sodium dithionite
was added until the organic layer becomes clear (methylene blue is converted to leuco-methylene
blue). The organic layer is then transferred to an RBF with sodium sulphate using canula transfer
to prevent oxidation of the leuco-methylene blue. Once the moisture is removed from the organic
layer, it is transferred to an RBF with 1.8 g NPC dissolved in sufficient quantity of toluene and the
reaction was propagated at 50 ºC for 15 minutes, TEA was used to induce basic conditions to the
reaction. The reaction mixture was filtered and washed thrice using base (saturated sodium
bicarbonate solution), thrice using acid (0.1 N HCl) and once with brine (Saturated solution of
sodium chloride). Water was removed using Sodium sulphate and the reaction mixture was
filtered. The filtrate was exposed to rotating vacuum evaporator to remove toluene from the
7

reaction mixture. The crude produce was recrystallized with acetonitrile, filtered, dried and stored
for further use. The crude product was characterized using 1H NMR. Activated MB was directly
conjugated to PEG-Linker to before introducing ethanolamine and characterized for its surface
activity.
Conjugation of activated methylene blue with ethanolamine
MB-NP (450 mg, 1.0 mmol) was dissolved in anhydrous THF (15 ml, with heating to speed up the
dissolution rate) yielding yellow/golden solution. The solution was added dropwise into 10 ml
THF containing ethanolamine (620 mg, 11.11 mmol) and triethylamine. The reaction mixture was
protected from light and refluxed at 60oC for 1 day and the reaction progress was checked using
TLC. The THF was removed using the rotating vacuum evaporator and the crude product was
dissolved in DCM. This solution was exposed to washing 3 times with NaHCO3 and water. The
obtained organic phase was dried using sodium sulphate and evaporated under reduced pressure
and subjected to flash column chromatography (hexane: ethyl acetate; 1:1). When all the impurities
were eluted out (monitored using TLC), 100% acetone was used as the mobile phase to elute out
MB-EA. The acetone was removed using the rotary vacuum evaporator and the product was dried
and characterized using 1H NMR.
Activation of MB-EA with 4-Nitophenyl chloroformate
Nitrophenyl chloroformate (400 mg, 2.0 mmol) was dissolved in DCM and the cooled MB-EA
(350 mg, 1.0 mmol) solution was prepared in DCM simultaneously. NPC in DCM was added
dropwise to the MB-EA solution in a round bottom flask on an ice bath. The RBF was removed
from the ice bath after 30 minutes and the reaction was propagated at room temperature for 12
hours (the progress of the reaction was checked using TLC plates). The reaction mixture was
washed with NaHCO3 and water. The collected organic phase was dried to 1 ml volume and
8

subjected to flash column chromatography using (Hexane: Ethyl acetate; 2:1) until all the
impurities were removed. Ethyl acetate was used to elute MB-EA-NP (activated MB-EA). The
eluted solution was evaporated under reduced pressure yielding a light brown product which was
characterized using 1H NMR.
Synthesis of Polyethylene Glycol (PEG)-Octamethylene diamine-Methylene Blue (MB) &
Polyethylene Glycol (PEG)-Octamethylene diamine-Ethanolamine-Methylene Blue (MB)
PEG-Linker and triethyl amine were dissolved in DCM and transferred to a round bottom flask.
Activated MB/MB-EA were dissolved in DCM and added dropwise to the RBF with constant
stirring. The final product was purified using excess cold diethyl ether and the precipitate was
subjected to purification by precipitation two times before drying. The dried product was
recrystallized using ethyl acetate and then characterized using 1H NMR.

Figure 5. Synthesis of POEM by conjugation of PEG-Linker with activated MB-EA.
Determination of light sensitivity by NIR irradiation
To confirm the sensitivity of the product to NIR radiation, the fluorescence of methylene blue
was used as an indicator. The first step of this experiment was to irradiate and the second step
was spectroscopic detection.
Irradiation procedures
A LumaCare® LC-122A equipped with 24W halogen lamp (non-coherent light source) and a 660
nm optic fiber probe with 325 mW/cm2 light intensity at the fiber tip was used for all NIR
irradiation experiments. The light intensity at the irradiated samples surface was estimated based
9

on the distance from the fiber tip to the sample, using a non-public-distribution excel worksheet
provided by LumaCare Medical Group. Normally, a 25.42 mm distance from tip will be subjected
to a 25 mW/cm2 incident light intensity. An Ultra-LUM UV crosslinker chamber, model AEX800 was used for all UV irradiation experiments. The 6 x 6-watt mercury lamps mounted on the
ceiling emits 365 nm wavelength light. The intensity of light inside the chamber varied from 1.5
to 2.0 mW/cm2 during the operating time.
Fluorescence and absorbance spectral measurements
Fluorescence measurements were performed using a LC500 Perkin Elmer fluorescence
spectrophotometer at 660 nm excitation wavelength, 600 to 800 nm emission wavelength, 10 nm
excitation slit and 10 nm emission slit. MB derivatives were completely dissolved and diluted in a
solvent mixture of acetone: 1 µM pH 7.4 phosphate buffer 70:30 unless otherwise stated. The
sample concentration was kept below 15 µM to guarantee the linear relationship between
fluorescence intensity, MB concentration and minimize MB aggregation. Exactly 1 ml of the tested
solution is loaded into fluorescence cell and sealed with a paraffin film to prevent solvent
evaporation during the irradiation process. Absorbance scans were performed using a Genesys 8
UV-VIS spectrophotometer. The sample’s concentration was kept at around 50 µM since the
detection sensitivity of absorbance method is lower than that of fluorescence.
Determination of Sensitivity to Reactive Oxygen Species (ROS)
Determination of sensitivity to ROS was conducted by preparing aqueous polymeric solution and
exposing it to three conditions i.e. H2O2, H2O2+Fe(II), H2O2+Peroxidase. For this experiment a 10
mM solution of H2O2, 10 mM solution of FeSO4, 500 µg/ml solution of the synthesized polymer
and 10 µg/ml of Peroxidase enzyme were prepared. The reaction vials with the composition shown
in Table 1 were prepared and stored in the dark for four days. The release was observed using UV10

Visible spectroscopic measurement. Absorbance was measured at 666 nm in the UV-Visible
Spectrophotometer.
Table 1. Vial compositions for the ROS sensitivity study.
*Vial Code Polymeric solution
H2O2 (10 µl)
(500 µl)
1(a)
*
1(b)
*
1(c)
*
1(d)
*
2(a)
*
*
2(b)
*
*
2(c)
*
*
2(d)
*
*
3(a)
*
*
3(b)
*
*
3(c)
*
*
3(d)
*
*
4
*
*
5
*
6
*
7
*
*Volume adjusted to 1 ml using DI water.

Fe(II) (10 µl)

Peroxidase
(10µl)

*
*
*
*
*
*
*

Thermal characterization
Thermal properties of a surfactant are important and can be exploited for the development of
formulations and selection of manufacturing processes. We used Differential Scanning
Calorimetry (DSC) and Thermogravimetric Analysis (TGA) for the thermal characterization of
this conjugate. DSC of the conjugate and PEG 2000 were performed at a ramp rate of 10ºC per
minute at a temperature range of 25-200ºC to inspect the change in the Tg of the polymer and to
assure the purity of the synthesized moiety. We also subjected the sample to TG analysis at the
same temperature range as DSC to inspect any degradation caused due to exposure to high
temperature.
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Determination of critical micellar concentration
The design of the product suggests potential surfactant properties. These surface-active properties
were confirmed using Tensiometry[24]. We used optical tensiometry to determine the surface
tension of water at different surfactant concentrations. First the tensiometer was calibrated using a
metallic calibration sphere for precision and the lens was adjusted to the highest resolution.
Calibration of the lens was repeated after each sample. A range of concentrations (5, 10, 20, 50,
100, 200, 300, 400, 500, 600, 700, 800, 1000, 1200 µg/ml) were used to determine the Critical
Micellar Concentration of the final product. After the experiment, a graph of Surface tension (γ)
vs Log[Concentration] was plotted. The point of CMC is considered as the end of the plateau
formed by a sharp decline which is followed by a constant surface tension.
Method of Analysis
For the accurate and efficient estimation of Paclitaxel in this research project, Waters alliance
e2695 HPLC separation module and Waters 2489 UV system was used using an existing HighPerformance Liquid Chromatographic method. The parameters for the used HPLC method are
mentioned in the following table 2[10].
Table 2. Parameters for HPLC detection
Parameters
Mobile Phase
Column

Set values
ACN:WATER (45:55)
LC-18-DB, Stainless steel, 250 mm X 4.6
mm, 5µ particle size
10 µl
230 nm
1 ml /ml

Injection volume
Detection wavelength
Flow rate
Retention time
Paclitaxel
Run time

10.70-10.90 minutes
15 minutes

Preparation of Paclitaxel loaded micelles
Paclitaxel was the model drug selected for the formation of micelles because of its extremely
12

hydrophobic nature. The micelles were prepared by two methods (Co-solvent evaporation method
and film hydration method) and the method with better encapsulation and loading efficiency was
selected. For the co-solvent evaporation method, both the drug (1mg) and the polymer (30 mg
POEM/200 mg Pluronic F127) were dissolved in 0.5 ml Acetonitrile. This solution was added drop
by drop to 3 ml of water with constant stirring and this mixture was stirred for 2 hours. After two
hours, this mixture was transferred to centrifuge tubes and exposed to centrifugation at 8000 RPM
for 10 minutes. The supernatant containing micelles was collected and stored for further use [13][15].
For the film hydration method, both Paclitaxel (5 mg) and polymer (30 mg POEM/200 mg Pluronic
F127) were dissolved in 2 ml of acetonitrile, this solution was stirred for 30 minutes and the ACN
was evaporated using a Rotary vacuum evaporator forming a film at the bottom of the RBF. This
film was hydrated by the drop by drop addition of DI water and the solution was stirred for 30
minutes[10]. This solution was transferred to centrifuge tubes and exposed to centrifugation at
13000 RPM for 10 minutes. The supernatant containing micelles was collected and stored in the
dark for further use.
Determination of the encapsulation and loading efficiency
100 µl of the prepared micellar solution were further diluted with 1 ml of Acetonitrile and
subjected to sonication for 10 minutes. This solution was then analyzed by a UV/VIS detector at
230 nm using a Kinetex® 5µm EVO C18, 250 x 4.6 mm, 100Å HPLC column and ACN:Water
(45:550) as the mobile phase. The loading and the encapsulation efficiencies were calculated using
the following equations[9][13][15].
𝑤
𝐴𝑚𝑜𝑢𝑛𝑡 𝑜𝑓 𝑙𝑜𝑎𝑑𝑒𝑑 𝑃𝑎𝑐𝑙𝑖𝑡𝑎𝑥𝑒𝑙 𝑖𝑛 𝑚𝑔
𝑃𝑎𝑐𝑙𝑖𝑡𝑎𝑥𝑒𝑙 𝑙𝑜𝑎𝑑𝑖𝑛𝑔 ( ) =
𝑤
𝐴𝑚𝑜𝑢𝑛𝑡 𝑜𝑓 𝑝𝑜𝑙𝑦𝑚𝑒𝑟 𝑖𝑛 𝑚𝑔
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𝐸𝑛𝑐𝑎𝑝𝑠𝑢𝑙𝑎𝑡𝑖𝑜𝑛 𝑒𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑐𝑦 (%) = (

𝐴𝑚𝑜𝑢𝑛𝑡 𝑜𝑓 𝑙𝑜𝑎𝑑𝑒𝑑 𝑃𝑎𝑐𝑙𝑖𝑡𝑎𝑥𝑒𝑙 𝑖𝑛 𝑚𝑔
) ∗ 100
𝐴𝑚𝑜𝑢𝑛𝑡 𝑜𝑓 𝑎𝑑𝑑𝑒𝑑 𝑃𝑎𝑐𝑙𝑖𝑡𝑎𝑥𝑒𝑙 𝑖𝑛 𝑚𝑔

In vitro Release Testing
The in vitro release testing was conducted for both Pluronic F127 and POEM based PTX loaded
micelles using a dialysis bag. A 100-hour release study was performed for PTX loaded micelles
prepared using Pluronic F127 and POEM. 1M Sodium Salicylate (pH 7.49) was used as a release
medium as it acts as a hydrotropic moiety and enhances the solubility of PTX in water [10]. The
prepared micelles were loaded in a cellulose bag (inertness of the bag was tested by incubating the
bag in PTX solution and determining the concentration before and after) and immersed in the
release media[10]. This setup was performed in two conditions i.e. in the dark and exposed to N-IR
radiation. 1 ml sample was withdrawn at each timepoint which was replaced with 1 ml of fresh
media to maintain sink conditions. The samples were estimated using HPLC. Plots of
concentration versus the square root of time indicated the kinetics of the performed release study.
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Chapter III: Results and discussion
Structural characterization of the synthesized intermediates and final product

Figure 6. 1H NMR of activated Methoxy PEG, first step for the synthesis of PEG-Linker.

Figure 7. 1H NMR of PEG-Linker, second and final product for the first part of the entire synthetic
scheme.
The Figure 6 shows the 1H NMR of activated Methoxy PEG which is the intermediate product for
the synthesis of the first major reactant i.e. PEG-Linker (Methoxy Polyethylene glycol conjugated
15

with Octamethylene diamine). Figure 7 shows the 1H NMR of the first major reactant for the
synthesis of the final product. The NMR suggests successful synthesis of the mentioned
intermediates.

Figure 8. 1H NMR of activated MB, first step for the synthesis of MB-EA-NP (activated MBEA)

Figure 9. 1H NMR of MB-EA, second step for the synthesis of MB-EA-NP (activated MB-EA)
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Figure 11. 1H NMR of MB-EA-NP, second major reactant for the synthesis of the final product.
Figure 9 and 10 show the 1H NMR of the first (MB-NP, activated Methylene Blue) and second
(MB-EA, Methylene blue conjugated with Ethanolamine) intermediate products synthesized.
Figure 11 shows the 1 HNMR of the second major reactant synthesized i.e. MB-EA-NP (activated
MB-EA). Further, figure 12 shows the FT-IR spectrum of the final product. The NMR shows
successful synthesis of all the intermediates and major reactants.

Figure 12. 1H NMR of the synthesized final product, POEM (PEG-Octamethylene diamineEthanolamine-Methylene blue)
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Figure13. FT-IR of the final synthesized product (POEM).
Figure 12 shows the 1H NMR of the final synthesized product. Further, Figure 13 shows the FTIR spectrum of the final product. From the FTIR, the functional groups present on POEM were
confirmed. The NMR and FT-IR spectral analysis confirms the successful synthesis of POEM.
Determination of light sensitivity by NIR irradiation
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Figure 14. MB release from POEM on exposure to N-IR radiation.
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Each timepoint shows an increase in the absorbance of the Methylene Blue, this suggests that the
methylene blue attached to the product is released on exposure to the N-IR radiation. On exposure
of the sample concentration to the N-IR radiation over 30 minutes, the increase in absorbance
ceases as seen in Figure 14 which shows complete release of methylene blue from the synthesized
product. This experiment illustrated the N-IR sensitive nature of the synthesized product.
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Figure 15. MB release from POEM on exposure to UV radiation.
Figure 15 shows the release of methylene blue on exposure to UV radiation. The increase in the
absorbance of the polymeric solution exposed to the UV radiation at different timepoints can be
clearly observed. This suggests and confirms the sensitivity of the synthesized product to UV
irradiation. Further, the absorbance ceases to increase after 20 minutes. This suggests all the
conjugated MB has been released within 20 minutes of exposure to UV radiation.

19

Determination of sensitivity to ROS

ROS Sensitivity (Hydrogen Peroxide+Peroxidase)
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Figure 16. Sensitivity of POEM to hydroxyl free radicals produced by using Peroxidase enzyme.
Sensitivity to ROS might further enhance the targeting provided by the synthesized polymer. This
experiment was conducted to predict the sensitivity of the polymer to ROS. The polymer solution
was exposed to hydrogen peroxide in the presence of Peroxidase (generates hydroxyl free radicals)
which released the conjugated MB instantly as seen in Figure 16. This confirms the sensitivity of
the polymer to the hydroxyl free radical in vitro.
This hypothesis was further bolstered by exposing the polymeric solution to hydrogen peroxide
which was converted to hydroxyl free radicals by Fe (II) ions. This is similar to the in vivo reaction
catalyzed by the iron present in hemoglobin. As predicted, the polymer instantly released all the
conjugated MB which could be visually observed by the color change in the polymeric solution
from colorless to dark blue. This observation was further supported by the change in absorbance
of the sample as displayed in Figure 17. The peak is similar to the polymer exposed to peroxide in
presence of peroxidase due to the strong catalytic nature of both peroxidase and Fe(II).
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ROS Sensitivity (Hydrogen Peroxide+Fe(II))
3.5
3

Absorbbance

2.5
2
1.5
1
0.5
0

-0.5

300

400

500

600

700

800

900

Wavelength
H2O2+Fe(II)

Blank

Figure 17. Sensitivity of POEM to hydroxyl free radicals produced by using Fe(II) ion.
Further the polymeric solution was exposed to peroxide solution for four days and the kinetics of
MB release due to peroxide was compared with release due to hydrolysis. The increase in the
absorbance was slow and gradual which confirmed that the polymer was more sensitive to
hydroxyl free radicals as compared to the peroxide radical as seen in Figure 18.
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Figure 18. Sensitivity to Hydrogen Peroxide (Peroxide free radical).
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Figure 19. Sensitivity to Hydrolysis.
From the comparative study of hydrolysis versus sensitivity to peroxide, it was observed that the
initial rate of MB release was similar but after 24 hours the rate of release due to peroxide increased
as compared to hydrolysis. At the end of day 3, the release was almost double as compared to
hydrolysis; hence it can be deduced that the polymer is sensitive to peroxide and hydroxyl free
radicals.
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Figure 20. Comparison between rate of hydrolysis and sensitivity to Peroxide radical.
Thermal characterization
The DSC profile of the polymer revealed a decrease in the melting peak when compared with PEG
2000. This reduction in the temperature of melting can be attributed to the inclusion of a big
conjugate in the PEG structure. A plasticizer increases space between polymer molecules which
reduces the temperature of melting of the given substance[27]. Attaching a large molecule like
methylene blue using a linker might have increased the space between two PEG polymers which
are closely stacked otherwise mimicking the activity of a plasticizer.

Figure 21.DSC overlay of MB, POEM and PEG 2000.
The TGA profile of the polymer did not show any degradation up to 200 ºC. This suggests one of
the two things. Firstly, the polymer is thermostable up to 200 ºC or the degradation or breakdown
of the polymer is not leading to a decline in the weight of the molecule (no volatile degradant
present). The first assumption is supported by the observation that no degradation peaks are visible
in the DSC profile. This suggests that the polymer is thermo-stable and can be subjected to high
temperature during formulation of a drug delivery platform.
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Determination of critical micellar concentration (CMC)

Critical Miceller Concentration
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Figure 22. Critical Micellar Concentration (CMC) determination using tensiometry, plot of
Surface tension versus Log of Concentration.
A plot of surface tension versus log of concentration was plotted to determine the surface tension
of the synthesized surfactant. The point of sharp decline was determined and considered as the
CMC of the surfactant[26].
Table 3. Observations of surface tension for various concentrations of synthesized polymer.
Concentration (mg/ml)
Log of Concentration
Surface tension
1E-6
-6.00
72.83±1.88
5E-5
-4.30
72.64±1.23
1E-4
-4.00
72.32±0.70
5E-4
-3.30
72.06±0.89
1E-3
-3.00
71.71±2.17
2.5E-2
-1.60
64.32±1.38
5E-2
-1.30
61.94±0.82
0.1
-1.00
60.57±0.72
0.25
-0.60
58.55±0.77
0.5
-0.30
57.44±0.96
1
0.00
56.63±1.07
2
0.30
55.09±0.75
2.5
0.39
55.14±1.87
4
0.60
55.67±1.07
5
0.69
55.74±1.24
8
0.90
55.87±0.90
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10

1

55.9±0.7

From the plot and the values, the CMC was found to be 250 g/ml for the synthesized surfactant.
It can be observed that the surface tension after the CMC was constant which shows that all the
unbalanced surface charge responsible for the surface tension of water was balanced by the
surfactant. The CMC can be used to determine the amount of polymer required to encapsulate the
model drug used in this research project. Furthermore, the concentration on polymer should be
maintained over CMC to ensure maximum encapsulation of the drug in the polymeric core. The
reduction of surface tension to 55 dynes/cm3 also shows that the polymer synthesized is not a very
powerful surfactant. This might delay the rate of self-assembly and micelle formation, hence
selection of an efficient method for the preparation of micelles is crucial.
Determination of the encapsulation and loading efficiency of paclitaxel loaded micelles
The encapsulation and loading efficiencies were determined using the calibration curve of PTX
taking 5,10,20,40 and 80 µg/ml concentrations. The calibration curve formed had an R2 of 0.999
and hence was used for estimation of PTX loaded in the micelles. The encapsulation and loading
efficiencies of POEM and Pluronic F127 are provided in Table 4.
Table 4. Summary of encapsulation and loading efficiency for POEM and Pluronic F127
Method of
Polymer Amount of Amount of Encapsulation
Loading
preparation
Polymer
Drug
efficiency
efficiency
(mg/ml)
Co-solvent
POEM
15
1
18.89±4.27
0.018±0.004
evaporation
Film hydration
POEM
15
5
86.97±1.03
0.14±0.0017
method
Co-solvent
P-F127
50
1
44.46±3.69
0.0044±0.0003
evaporation
Film hydration
P-F127
50
5
07.63±0.10
0.0019±0.000028
method
It can be seen that the film hydration method provided a better and higher encapsulation efficiency
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as compared to the co solvent evaporation method for POEM. This could be attributed to the design
of the preparation method as the slow evaporation of ACN provides sufficient time to the polymer
for self-assembly (micelle formation) and the drug is already incorporated in the polymeric matrix
during the hydration of film. This facilitates the encapsulation of drug in the micellar core. In
contrast to the film hydration method, co-solvent evaporation does not provide enough time for
the formation of micelles as the organic phase is added to the aqueous phase and due to the sudden
change in the environment majority of the API gets precipitated out. Only the drug present in close
vicinity to the polymeric clusters are stabilized in the micellar core which results in lower
encapsulation of the API.
In vitro Release Testing Studies
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Figure 22. in vitro release profiles of PTX loaded P-F127 and POEM based micelles.
The membrane was found to be inert and absorbed only 299 ng of drug from the solution which
was insignificant as compared to the loaded drug amount. The in vitro release studies performed
in dark showed a constant gradual increase in the concentration of PTX from both P-F127 and
POEM based micelles. The release of the drug from POEM could be attributed to the release due
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to hydrolysis of the polymer but as seen in the studies conducted above, the rate of hydrolysis is
and should be further hindered due to the micellar aggregation of the polymer as the MB part forms
the hydrophobic core stabilizing the urea bond from instant hydrolysis. This confirms our
hypothesis that the drug will not be released completely from the self-assembled nanoparticle
unless exposed to an external stimulus (N-IR, UV or ROS).
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Figure 23. in vitro release profiles of PTX loaded P-F127 and POEM based micelles.
The above-mentioned claim was supported by the burst release of PTX observed when the release
assembly was exposed to N-IR radiation after keeping it protected from light for the first hour of
the experiment. This burst release of the drug on exposure to N-IR stimuli can be confirmed from
this experiment. Furthermore, P-F127 which was used as a control for this experiment displayed
insignificant difference between the two experimental conditions. This confirmed that the release
of the drug was because of the light sensitivity of the polymer.
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CHAPTER IV: CONCLUSION
Cancer targeting is slowly becoming an important aspect of cancer chemotherapy because of the
severe side effects observed in conventional chemotherapy. The objective of synthesizing a novel
light sensitive, self-assembling polymer for the potential targeted delivery of chemotherapeutic
agents was successfully performed. Synthesis and structural characterization of all the
intermediates and the final product were performed and interpreted successfully. Furthermore, the
sensitivity of the synthesized polymeric entity towards N-IR, UV and ROS were depicted through
in vitro experimental models. The surface-active property and thermal characteristics of the
polymer were investigated and reported successfully. Based on the CMC, PTX was successfully
loaded into POEM based micelles. Release studies to confirm the release of PTX on exposure to
N-IR irradiation were successfully conducted and the burst release of PTX from the micelles on
exposure to stimuli was confirmed with the in vitro release studies. From the experimentation and
characterization performed, it can be concluded that POEM is a light sensitive, surface active
polymeric entity with self-aggregating properties which can be used to develop a targeted
nanoparticulate drug delivery platform. Further studies such as ex vivo cell viability assays,
cytotoxicity assays using cell lines and in vivo studies on animal models should be performed after
optimizing the nanoparticulate formulation in order to bolster the use of POEM in cancer targeting.
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